Many antihistamines exhibit inhibition of mediator release from mast cells
and basophils, in in vitro studies in addition to H-1 antagonism. The under
lying mechanism is unclear but is unrelated to H-1-receptor antagonism. Cli
nical studies of antihistamins in antigen challenge and seasonal allergy de
monstrate reduction of mast cell mediators in nasal lavage. It is not known
what mechanism(s) underly these observations, although the concentrations
required in in vitro studies suggests that a direct effect on mast cells is
unlikely. Furthermore, the therapeutic contribution of this effect is diff
icult to assess because of concomitant clinically significant H-1 antagonis
m. This and other potential anti-allergic effects may enhance the therapeut
ic benefit of antihistamines and long-term studies are underway to explore
this possibility.